In this webinar we will explore solutions to the underdetection of cognitive disease. We’ll talk about the role of routine cognitive screening and new innovations that aid in accurate and timely assessment. We’ll highlight cognitive screening workflows for in-clinic or virtual care. We’ll discuss ways to overcome common barriers to detection, including some of the pain points raised by healthcare leaders at the AMGA Fall Council Summit (e.g. staffing and retention). We’ll also touch on reimbursement, ROI, and related developments in Medicare V28 and the new CMS GUIDE Model.
Key takeaways:
You’ll discover:
● New tools & strategies to address the underdetection of MCI, Alzheimer’s and other dementias
● Top concerns raised by health leaders at the AMGA Fall Council Summit and their impact on cognitive care
● Noteworthy CMS developments, including V28 changes to dementia codes and the GUIDE Model